Two Sigma Investments’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Two Sigma Investments’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-109,131	Closed	-$11.1M	–	3352
2023 Q2	$11.1M	Sell	109,131 -15,449	-12%	-$1.46M	0.03%	594
2023 Q1	$11.3M	Sell	124,580 -20,864	-14%	-$1.22M	0.03%	546
2022 Q4	$5.53M	Buy	145,444 +97,329	+202%	+$3.35M	0.02%	808
2022 Q3	$1.21M	Buy	+48,115	New	+$1.33M	﹤0.01%	1378
2022 Q1	–	Sell	-102,002	Closed	-$2.69M	–	4681
2021 Q4	$2.69M	Buy	+102,002	New	+$7.89M	0.01%	1659
2020 Q2	–	Sell	-51,682	Closed	-$7.46M	–	3673
2020 Q1	$7.46M	Buy	+51,682	New	+$9.98M	0.06%	344
2019 Q2	–	Sell	-24,147	Closed	-$2.06M	–	3766
2019 Q1	$2.06M	Buy	+24,147	New	+$2M	0.01%	1397

Other funds holding RETA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Two Sigma Investments's RETA Position: Q3 2023 in Review

Two Sigma Investments sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2023, closing a stake of 109,131 shares — an estimated $11.1M sold.

Two Sigma Investments first reported a position in RETA in Q1 2019 and held it in 7 quarters. The position peaked at $11.3M in Q1 2023. 2 funds tracked by Wall St. Rank hold RETA as of Q3 2023.

Two Sigma Investments reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Two Sigma Investments sold 109,131 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2023, an estimated $11.1M.
Two Sigma Investments first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q1 2019 and held it in 7 quarters.
Two Sigma Investments's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $11.3M in Q1 2023.
2 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2023.

Based on Two Sigma Investments's 13F filing for Q3 2023, filed 14 Nov 2023.